Target intelligence / Profile preview

RNA, U6 small nuclear 1029, pseudogene (RNU6-1029P)

Target: RNU6-1029P
Molecular classification: Other (processed pseudogene; snRNA pseudogene)

Overview

**RNA, U6 small nuclear 1029, pseudogene** (RNU6-1029P) is a non-coding genomic sequence classified as a *processed pseudogene* of the U6 small nuclear RNA (snRNA) family[1][3][7][9]. Pseudogenes like RNU6-1029P originate from retrotransposition or duplication events of parental snRNA genes, leading to non-functional copies that usually lack the regulatory or coding potential of their progenitor[2]. The U6 snRNA molecules are fundamental components of the spliceosome, responsible for mRNA splicing, but processed pseudogenes like RNU6-1029P do not contribute to splicing or any known cellular process[2]. While some pseudogenes have been linked to gene regulation through small RNA production or as miRNA decoys, there is no direct evidence that RNU6-1029P participates in such mechanisms[4]. Its primary function is as a passive marker of historical retrotransposition activity in the genome[2][8]. This pseudogene has no direct clinical, biomarker, or therapeutic relevance[1][3][4][9].

Other names: RNU6-1029P

Biological functions

None (does not have a known biological function; processed pseudogenes typically do not encode functional products in the cell)

Disease associations

Other (no known direct role in disease; pseudogenes, however, have been implicated in gene expression regulation through small interfering RNA or miRNA decoy function in some contexts, but not for this specific pseudogene)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1029, pseudogene (RNU6-1029P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1029, pseudogene (RNU6-1029P).

Explore the full profile